{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:28:15Z","timestamp":1791520095505,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370558"],"award-info":[{"award-number":["82370558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05865-6","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T12:34:46Z","timestamp":1734698086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ABL1\u2012YAP1 axis in intestinal stem cell activated by deoxycholic acid contributes to hepatic steatosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Tiancheng","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lungen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"1","key":"5865_CR1","first-page":"174","volume":"11","author":"J Ji","year":"2023","unstructured":"Ji J, Wu L, Wei J, Wu J, Guo C. The gut microbiome and ferroptosis in MAFLD. J Clin Transl Hepatol. 2023;11(1):174\u201387.","journal-title":"J Clin Transl Hepatol"},{"issue":"7","key":"5865_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","volume":"24","author":"L Hoyles","year":"2018","unstructured":"Hoyles L, Fern\u00e1ndez-Real J-M, Federici M, Serino M, Abbott J, Charpentier J, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med. 2018;24(7):1070\u201380.","journal-title":"Nat Med"},{"key":"5865_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, et al. Intestinal permeability\u2014a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"5865_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799\u2013809.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5865_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41575-018-0081-y","volume":"16","author":"H Gehart","year":"2019","unstructured":"Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16(1):19\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5865_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415578","author":"L Liu","year":"2022","unstructured":"Liu L, Xu J, Xu X, Mao T, Niu W, Wu X, et al. Intestinal stem cells damaged by deoxycholic acid via AHR pathway contributes to mucosal barrier dysfunction in high-fat feeding mice. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232415578.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5865_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.tem.2022.01.002","volume":"33","author":"J Martel","year":"2022","unstructured":"Martel J, Chang S-H, Ko Y-F, Hwang T-L, Young JD, Ojcius DM. Gut barrier disruption and chronic disease. Trends Endocrinol Metab. 2022;33(4):247\u201365.","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"5865_CR8","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"4","key":"5865_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/gutjnl-2011-301012","volume":"61","author":"M Serino","year":"2012","unstructured":"Serino M, Luche E, Gres S, Baylac A, Berg\u00e9 M, Cenac C, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut. 2012;61(4):543\u201353.","journal-title":"Gut"},{"issue":"1","key":"5865_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/advances\/nmz061","volume":"11","author":"MW Rohr","year":"2020","unstructured":"Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative effects of a high-fat diet on intestinal permeability: a review. Adv Nutr. 2020;11(1):77\u201391.","journal-title":"Adv Nutr"},{"issue":"1","key":"5865_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mrrev.2004.08.001","volume":"589","author":"H Bernstein","year":"2005","unstructured":"Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005;589(1):47\u201365.","journal-title":"Mutat Res"},{"key":"5865_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/nature12347","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013. https:\/\/doi.org\/10.1038\/nature12347.","journal-title":"Nature"},{"issue":"10","key":"5865_CR13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","volume":"67","author":"N Jiao","year":"2018","unstructured":"Jiao N, Baker SS, Chapa-Rodriguez A, Liu W, Nugent CA, Tsompana M, et al. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2018;67(10):1881\u201391.","journal-title":"Gut"},{"issue":"2","key":"5865_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/hep.29359","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri P, Daita K, Joyce A, Mirshahi F, Santhekadur PK, Cazanave S, et al. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology. 2018;67(2):534\u201348.","journal-title":"Hepatology"},{"issue":"6","key":"5865_CR15","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/hep.32568","volume":"76","author":"E Smirnova","year":"2022","unstructured":"Smirnova E, Muthiah MD, Narayan N, Siddiqui MS, Puri P, Luketic VA, et al. Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD. Hepatology. 2022;76(6):1811\u201324.","journal-title":"Hepatology"},{"issue":"1","key":"5865_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Harris SC, Bhowmik S, Kang D-J, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7(1):22\u201339.","journal-title":"Gut Microbes"},{"key":"5865_CR17","doi-asserted-by":"publisher","first-page":"1021924","DOI":"10.3389\/fimmu.2022.1021924","volume":"13","author":"N Calzadilla","year":"2022","unstructured":"Calzadilla N, Comiskey SM, Dudeja PK, Saksena S, Gill RK, Alrefai WA. Bile acids as inflammatory mediators and modulators of intestinal permeability. Front Immunol. 2022;13:1021924.","journal-title":"Front Immunol"},{"issue":"3","key":"5865_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","volume":"159","author":"G Sorrentino","year":"2020","unstructured":"Sorrentino G, Perino A, Yildiz E, El Alam G, Bou Sleiman M, Gioiello A, et al. Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration. Gastroenterology. 2020;159(3):956.","journal-title":"Gastroenterology"},{"key":"5865_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051214","author":"H Zeng","year":"2019","unstructured":"Zeng H, Umar S, Rust B, Lazarova D, Bordonaro M. Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20051214.","journal-title":"Int J Mol Sci"},{"key":"5865_CR20","doi-asserted-by":"publisher","first-page":"31538","DOI":"10.1038\/srep31538","volume":"6","author":"D Li","year":"2016","unstructured":"Li D, Cao W. Bile acid receptor TGR5, NADPH oxidase NOX5-S and CREB mediate bile acid-induced DNA damage in Barrett\u2019s esophageal adenocarcinoma cells. Sci Rep. 2016;6:31538.","journal-title":"Sci Rep"},{"issue":"5","key":"5865_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/carcin\/23.5.839","volume":"23","author":"B Glinghammar","year":"2002","unstructured":"Glinghammar B, Inoue H, Rafter JJ. Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Carcinogenesis. 2002;23(5):839\u201345.","journal-title":"Carcinogenesis"},{"issue":"11","key":"5865_CR22","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1039\/C8FO01143E","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu L, Dong W, Wang S, Zhang Y, Liu T, Xie R, et al. Deoxycholic acid disrupts the intestinal mucosal barrier and promotes intestinal tumorigenesis. Food Funct. 2018;9(11):5588\u201397.","journal-title":"Food Funct"},{"issue":"3","key":"5865_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.molcel.2007.12.022","volume":"29","author":"D Levy","year":"2008","unstructured":"Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell. 2008;29(3):350\u201361.","journal-title":"Mol Cell"},{"issue":"18","key":"5865_CR24","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1101\/gad.13.18.2400","volume":"13","author":"R Plattner","year":"1999","unstructured":"Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 1999;13(18):2400\u201311.","journal-title":"Genes Dev"},{"issue":"3","key":"5865_CR25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI122440","volume":"129","author":"B Li","year":"2019","unstructured":"Li B, He J, Lv H, Liu Y, Lv X, Zhang C, et al. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. J Clin Invest. 2019;129(3):1167\u201379.","journal-title":"J Clin Invest"},{"key":"5865_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153138","volume":"470","author":"F Ren","year":"2022","unstructured":"Ren F, Ning H, Ge Y, Yin Z, Chen L, Hu D, et al. Bisphenol A induces apoptosis in response to DNA damage through c-Abl\/YAPY357\/ p73 pathway in P19 embryonal carcinoma stem cells. Toxicology. 2022;470: 153138.","journal-title":"Toxicology"},{"issue":"4","key":"5865_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.molcel.2005.04.008","volume":"18","author":"S Strano","year":"2005","unstructured":"Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, et al. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell. 2005;18(4):447\u201359.","journal-title":"Mol Cell"},{"issue":"2","key":"5865_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.devcel.2020.06.025","volume":"54","author":"C Ibar","year":"2020","unstructured":"Ibar C, Irvine KD. Integration of hippo-YAP signaling with metabolism. Dev Cell. 2020;54(2):256\u201367.","journal-title":"Dev Cell"},{"issue":"2","key":"5865_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jhep.2021.09.032","volume":"76","author":"J Qing","year":"2022","unstructured":"Qing J, Ren Y, Zhang Y, Yan M, Zhang H, Wu D, et al. Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis. J Hepatol. 2022;76(2):394\u2013406.","journal-title":"J Hepatol"},{"key":"5865_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.116081","volume":"305","author":"K Zheng","year":"2023","unstructured":"Zheng K, Zhou W, Ji J, Xue Y, Liu Y, Li C, et al. Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction-associated fatty liver disease. J Ethnopharmacol. 2023;305: 116081.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5865_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrd4161","volume":"13","author":"R Johnson","year":"2014","unstructured":"Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13(1):63\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"5865_CR32","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105770","volume":"40","author":"O Guillermin","year":"2021","unstructured":"Guillermin O, Angelis N, Sidor CM, Ridgway R, Baulies A, Kucharska A, et al. Wnt and Src signals converge on YAP-TEAD to drive intestinal regeneration. EMBO J. 2021;40(13): e105770.","journal-title":"EMBO J"},{"issue":"2","key":"5865_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41419-017-0244-8","volume":"9","author":"F Deng","year":"2018","unstructured":"Deng F, Peng L, Li Z, Tan G, Liang E, Chen S, et al. YAP triggers the Wnt\/\u03b2-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury. Cell Death Dis. 2018;9(2):153.","journal-title":"Cell Death Dis"},{"key":"5865_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8120560","author":"Y Seo","year":"2020","unstructured":"Seo Y, Park S-Y, Kim H-S, Nam J-S. The Hippo-YAP signaling as guardian in the pool of intestinal stem cells. Biomedicines. 2020. https:\/\/doi.org\/10.3390\/biomedicines8120560.","journal-title":"Biomedicines."},{"issue":"1","key":"5865_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","volume":"19","author":"N Zhang","year":"2010","unstructured":"Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, et al. The Merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19(1):27\u201338.","journal-title":"Dev Cell"},{"key":"5865_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.112815","volume":"178","author":"T Hu","year":"2020","unstructured":"Hu T, An Z, Shi C, Li P, Liu L. A sensitive and efficient method for simultaneous profiling of bile acids and fatty acids by UPLC-MS\/MS. J Pharm Biomed Anal. 2020;178: 112815.","journal-title":"J Pharm Biomed Anal"},{"key":"5865_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2016.12.016","volume":"15","author":"J Zhang","year":"2017","unstructured":"Zhang J, Gupte J, Gong Y, Weiszmann J, Zhang Y, Lee KJ, et al. Chronic over-expression of fibroblast growth factor 21 increases bile acid biosynthesis by opposing FGF15\/19 action. EBioMedicine. 2017;15:173\u201383.","journal-title":"EBioMedicine"},{"key":"5865_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225727","author":"ZS Wen","year":"2019","unstructured":"Wen ZS, Du M, Tang Z, Zhou TY, Zhang ZS, Song HH, et al. Low molecular seleno-aminopolysaccharides protect the intestinal mucosal barrier of rats under weaning stress. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20225727.","journal-title":"Int J Mol Sci"},{"issue":"7592","key":"5865_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature17173","volume":"531","author":"S Beyaz","year":"2016","unstructured":"Beyaz S, Mana MD, Roper J, Kedrin D, Saadatpour A, Hong S-J, et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature. 2016;531(7592):53\u20138.","journal-title":"Nature"},{"issue":"14","key":"5865_CR40","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1016\/j.yexcr.2007.05.019","volume":"313","author":"M Hesse","year":"2007","unstructured":"Hesse M, Grund C, Herrmann H, Br\u00f6hl D, Franz T, Omary MB, et al. A mutation of keratin 18 within the coil 1A consensus motif causes widespread keratin aggregation but cell type-restricted lethality in mice. Exp Cell Res. 2007;313(14):3127\u201340.","journal-title":"Exp Cell Res"},{"issue":"2","key":"5865_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","volume":"65","author":"F Del Chierico","year":"2017","unstructured":"Del Chierico F, Nobili V, Vernocchi P, Russo A, De Stefanis C, Gnani D, et al. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology. 2017;65(2):451\u201364.","journal-title":"Hepatology"},{"issue":"2","key":"5865_CR42","first-page":"227","volume":"9","author":"W Hern\u00e1ndez-Ceballos","year":"2021","unstructured":"Hern\u00e1ndez-Ceballos W, Cordova-Gallardo J, Mendez-Sanchez N. Gut microbiota in metabolic-associated fatty liver disease and in other chronic metabolic diseases. J Clin Transl Hepatol. 2021;9(2):227\u201338.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"5865_CR43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen F, Zheng RD, Sun XQ, Ding WJ, Wang XY, Fan JG. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2017;16(4):375\u201381.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"5865_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"issue":"1","key":"5865_CR45","doi-asserted-by":"publisher","first-page":"2372881","DOI":"10.1080\/19490976.2024.2372881","volume":"16","author":"HJ Zhong","year":"2024","unstructured":"Zhong HJ, Zhuang YP, Xie X, Song JY, Wang SQ, Wu L, et al. Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16\/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease. Gut Microbes. 2024;16(1):2372881.","journal-title":"Gut Microbes"},{"issue":"11","key":"5865_CR46","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.cgh.2022.11.030","volume":"21","author":"J Soppert","year":"2023","unstructured":"Soppert J, Brandt EF, Heussen NM, Barzakova E, Blank LM, Kuepfer L, et al. Blood endotoxin levels as biomarker of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21(11):2746\u201358.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"5865_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106572","volume":"26","author":"Z Shen","year":"2023","unstructured":"Shen Z, Shen B, Dai W, Zhou C, Luo X, Guo Y, et al. Expansion of macrophage and liver sinusoidal endothelial cell subpopulations during non-alcoholic steatohepatitis progression. iScience. 2023;26(5): 106572.","journal-title":"iScience."},{"issue":"7330","key":"5865_CR48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature09637","volume":"469","author":"T Sato","year":"2011","unstructured":"Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469(7330):415\u20138.","journal-title":"Nature"},{"issue":"7575","key":"5865_CR49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nature15382","volume":"526","author":"A Gregorieff","year":"2015","unstructured":"Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, Wrana JL. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer. Nature. 2015;526(7575):715\u20138.","journal-title":"Nature"},{"issue":"9","key":"5865_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113118","volume":"42","author":"Y An","year":"2023","unstructured":"An Y, Wang C, Fan B, Wang Z, Li Y, Kong F, et al. LSR targets YAP to modulate intestinal Paneth cell differentiation. Cell Rep. 2023;42(9): 113118.","journal-title":"Cell Rep"},{"key":"5865_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138881","author":"H Zhou","year":"2020","unstructured":"Zhou H, Zhou S-Y, Gillilland M, Li J-Y, Lee A, Gao J, et al. Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.138881.","journal-title":"JCI Insight."},{"issue":"6","key":"5865_CR52","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s12272-024-01501-5","volume":"47","author":"NY Lee","year":"2024","unstructured":"Lee NY, Choi MG, Lee EJ, Koo JH. Interplay between YAP\/TAZ and metabolic dysfunction-associated steatotic liver disease progression. Arch Pharm Res. 2024;47(6):558\u201370.","journal-title":"Arch Pharm Res"},{"issue":"2","key":"5865_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41575-020-00365-6","volume":"18","author":"C Zhu","year":"2021","unstructured":"Zhu C, Tabas I, Schwabe RF, Pajvani UB. Maladaptive regeneration\u2014the reawakening of developmental pathways in NASH and fibrosis. Nat Rev Gastroenterol Hepatol. 2021;18(2):131\u201342.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"5865_CR54","first-page":"935","volume":"8","author":"MH Cohen","year":"2002","unstructured":"Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res. 2002;8(5):935\u201342.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"5865_CR55","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/wjs.12210","volume":"48","author":"TJR Lam","year":"2024","unstructured":"Lam TJR, Udonwa SA, Masuda Y, Yeo MHX, Farid Bin Harunal Ras M, Goh BKP. A systematic review and meta-analysis of neoadjuvant imatinib use in locally advanced and metastatic gastrointestinal stromal tumors. World J Surg. 2024;48(7):1681\u201391.","journal-title":"World J Surg"},{"issue":"1","key":"5865_CR56","doi-asserted-by":"publisher","first-page":"15331","DOI":"10.1038\/s41598-018-32853-w","volume":"8","author":"S AlAsfoor","year":"2018","unstructured":"AlAsfoor S, Rohm TV, Bosch AJT, Dervos T, Calabrese D, Matter MS, et al. Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver. Sci Rep. 2018;8(1):15331.","journal-title":"Sci Rep"},{"issue":"2","key":"5865_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11605-011-1764-7","volume":"16","author":"WL Kuo","year":"2012","unstructured":"Kuo WL, Yu MC, Lee JF, Tsai CN, Chen TC, Chen MF. Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice. J Gastrointest Surg. 2012;16(2):361\u20139.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"5865_CR58","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.celrep.2016.10.023","volume":"17","author":"DH Kim","year":"2016","unstructured":"Kim DH, Kim J, Kwon JS, Sandhu J, Tontonoz P, Lee SK, et al. Critical Roles of the Histone Methyltransferase MLL4\/KMT2D in Murine Hepatic Steatosis Directed by ABL1 and PPAR\u03b32. Cell Rep. 2016;17(6):1671\u201382.","journal-title":"Cell Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05865-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05865-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05865-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T13:04:26Z","timestamp":1734699866000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05865-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5865"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05865-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"4 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee of the Shanghai General Hospital (protocol code 2021SQ205, 1 Match 2021). The human study was approved by the Ethics Committee of the Shanghai General Hospital (approval ID 20240226025226875). The study protocol adhered to the ethical principles of medical research involving human subjects as outlined in the 2013 Helsinki Declaration and the 2018 Istanbul Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest or financial conflicts to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1119"}}